PRIMA Canada logo

HomeGeneral Prenatal CareSpecific SubstancesPerinatal, Postpartum and Early ChildhoodLinks & Resources

Specific Substances

Alcohol
Nicotine
Marijuana
Opiates
Benzodiazepines
Stimulants
Inhalants
Hallucinogens & Designer Drugs

Supported by an unrestricted educational grant from
The Lawson Foundation

 

Hallucinogens and Designer Drugs

Drug

Type

Acute Effects

Medical Complications

Ketamine

Dissociative anaesthetic

Sedation, delirium, hallucinations

Respiratory depression, dysrhythmias, seizures

Ecstasy

Serotonergic effects

Feelings of warmth, empathy

Dehydration (common at "raves"); hyperthermia

Phencyclidine

Dissociative anaesthetic

Delirium, delusions, hallucinations, sedation

Seizures, hyperpyrexia, hypertension, coma, rhabdomyolysis, violence

Gamma Hydroxybutyrate (GHB)

GABA effects (neuroinhibitory)

Sedation, disinhibition, delirium

Prolonged, severe withdrawal in daily users: tremor, psychosis, delirium, seizures

 

Drug

Chronic Effects

Fetal Effects

Ketamine

Unknown

Possible neuro-developmental damage*

Ecstasy

?Long-term memory impairment

Possible cardiac, skeletal abnormalities

Phencyclidine

Memory impairment, depression

Possible neuro-developmental damage*

Gamma Hydroxybutyrate (GHB)

Coma, respiratory depression

Possible neuro-developmental damage*


*Animal studies have found that intoxicating doses of NMDA antagonists and GABAmimetic drugs cause apoptotic neuronal cell death in developing brains. These drugs include alcohol, ketamine, phencyclidine, benzodiazepines, barbiturates and anticonvulsants.

 

This site last edited: June 2008